Aaron G.l. Fletcher, Director at Cue Biopharma, Inc. (CUE), bought 13,096 shares at $12.64 ($166K) on 2020-11-24, disclosed to the SEC on 2020-11-25.
Open-market purchase of $166k CUE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.64 | 6,548 | $83K | 50.0% |
| 2 | $12.64 | 6,548 | $83K | 50.0% |
| Total | $12.64 avg | 13,096 | $166K | 100% |
| Filing → |
| TFFP | BUY | 2022-11-23 | $50K | — | Filing → |
| CUE | BUY | 2022-05-25 | $712K | — | Filing → |
| TFFP | BUY | 2022-05-17 | $538K | — | Filing → |